Skip to content

Prediction of CRT implantation benefit with Milrinone stress echocardiography

Evaluation of contractile reserve by Milrinone as a predictor of response to Cardiac Resynchronization Therapy in patients with heart failure.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201201238808N1
Enrollment
30
Registered
2012-03-18
Start date
2011-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure. Heart failure

Interventions

Before CRT implantation and after performing basic echocardiography, drug administrating ( Milrinone ) with loading dose 50 microgram/kg BW in 10 miuntes and continuing 5 microgram/kg/minute for 10 t
Diagnosis

Sponsors

Tabriz University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Heart failure patients who have LBBB with sinus rhythm, QRS>120msec, LVEF<35%, NIHA function class 3 & 4 and poor response to medical therapy. Exclusion criteria: Hypersensitivity to Milrinone,AF rhythm,severe COPD, hypertrophic and restrictive cardiomyopathies, acute myocarditis, correctable valvular diseases and acute coronary syndrome.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Echocardiographic Values of left ventricular contractility. Timepoint: Admission time( basic & with Milrinon ),4- 6 months afterCRT implantation. Method of measurement: Echocardiography.

Secondary

MeasureTime frame
NIHA function class ,frequency of hospitalization. Timepoint: Before & 4- 6 months after intervention. Method of measurement: 6 minute walking test, history.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKarim Mohammadi Kheyrabadi

Tabriz University of Medical Science

kheyrabadikm@tbzmed.ac.irkheyrabadi_km@yahoo.commtoufan@gmail.comF_akbarzadeh@yahoo.com+98 41 1336 3880

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026